Zenas BioPharma (NASDAQ:ZBIO) shares fell more than 50% in the last trading session following the release of Phase 3 results for obexelimab in patients with immunoglobulin G4-related disease (IgG4-RD).While the trial demonstrated a meaningful reduction in flare risk, efficacy metrics fell short of market expectations, triggering a sharp repricing in the stock. However, when viewed through the Adhishthana framework, this decline appears far from surprising. The stock's cyclical positioning had already signal ...

Broadcom (NASDAQ:AVGO) entered the final stage of its 18-phase Adhishthana cycle on the daily charts on 26 December. In our previous commentary published in late May 2025, we highlighted that the stock was setting up for a bullish breakout while trading near the $230 level. Since then, the move has played out decisively, with Broadcom rallying more than 80% and printing highs near $414.Now that the stock has reached the closing stretch of its cycle, it is worth reassessing the structure under the Adhishthan ...

Lamb Weston (NYSE:LW) has struggled to regain momentum since July 2023. The stock has remained under persistent selling pressure and continues to trade with pronounced bearish sentiment. When viewed through the Adhishthana framework, this weakness is not incidental but structural. Let's break down how the stock's weekly and monthly cycles deteriorated and what that implies going forward.The Weekly Chart Breakdown On the weekly charts, Lamb Weston is currently in Phase 12 of its 18-phase Adhishthana cycle. T ...

With Netflix and Paramount practically wrestling over who gets to paint their logo on Warner Bros’ water tower, shareholders are getting the best action sequence of all.Warner Bros (NASDAQ:WBD) has been in the spotlight after Netflix announced on December 5 that it would acquire the company for $72 million in equity value. What followed has brought even more drama to the story. First came reports that the Justice Department might intervene in the transaction. Then Paramount entered the scene with a hostile ...

Core Insights - Six Flags Entertainment Corporation's stock is experiencing a significant decline, currently in Phase 17 of its 18-phase Adhishthana cycle, indicating a continued weak outlook ahead [1][4]. Group 1: Stock Performance and Phases - The stock has shown no bullishness since entering Phase 14 in February 2024, with a decline of over 50% during this period, reflecting strong selling pressure [4]. - The absence of Satoguna in the Guna Triads suggests that the stock will not achieve a Nirvana move in Phase 18, which is expected to last from January 2026 to July 2027 [2][4]. Group 2: Investor Sentiment and Recommendations - Warning signs for the stock emerged between Phases 7 and 8 when it broke its Cakra formation to the downside, indicating deeper fundamental issues [5]. - Given the technical and cyclical context, it is advised that investors avoid Six Flags stock, as it offers little reward for the associated risk [6].

Core Viewpoint - Installed Building Products (IBP) is currently in Phase 17 of its 18-phase Adhishthana cycle, raising concerns about the sustainability of its stock rally in the long term [1][5]. Summary by Sections Adhishthana Framework - The Guna Triads, consisting of Phases 14, 15, and 16, are crucial for determining if IBP can achieve Nirvana in Phase 18, which is the peak of the cycle [4]. - The absence of Satoguna in all three phases of the Guna Triads indicates a low probability of a strong and sustained rally in the upcoming Phase 18, scheduled from January 2026 to July 2027 [4]. Current Stock Performance - Although the current rally in IBP shares appears robust, the weak triad formation suggests that momentum may slow down once Phase 18 begins [5]. - Phase 17 is characterized as a no-action phase, which aligns with the outlook indicated by the weak triads [5]. Investor Considerations - Existing investors may continue to hold the stock to capitalize on the current upside, but they should be cautious as the rally's strength may diminish before the end of Phase 17 [6]. - The lack of Satoguna in IBP's triads limits the potential for a sustained long-term rally, making the stock more suitable for short-term trading rather than new long-term investments [7].